Fecal Lactoferrin

3. Brandt LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W, et al. Systematic review
on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002
Nov;97(11 Suppl):S7-26.
4. Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: a new parameter to monitor infliximab
therapy. Dig Dis Sci. 2004 Jun;49(6):1036-9.
5. Butterton JR, Calderwood SB. Acute infectious diarrheal diseases and bacterial food poisoning.
In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL editors. Harrison’s
Principles of Internal Medicine. McGraw-Hill Co; 2004.
6. Cash BD, Chey WD. Diagnosis of irritable bowel syndrome. Gastroenterol Clin North Am. 2005
Jun;34(2):205-20.
7. Choi SW, Park CH, Silva TM, Zaenker EI, Guerrant RL. To culture or not to culture: fecal
lactoferrin screening for inflammatory bacterial diarrhea. J Clin Microbiol. 1996 Apr;34(4):928-32.
8. Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
Minerva Med. 2004 Oct;95(5):427-41.
9. D'Inca R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, et al. Calprotectin and
lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis.
2006 Jul 13.
10. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel
syndrome. Gastroenterology. 2002 Dec;123(6):2108-31.
11. DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters
Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997
Nov;92(11):1962-75.
12. Fass R, Longstreth GF, Pimentel M, Fullerton S, Russak SM, Chiou CF, et al. Evidence- and
consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern
Med. 2001 Sep 24;161(17):2081-8.
13. Granville LA, Cernoch P, Land GA, Davis JR. Performance assessment of the fecal leukocyte
test for inpatients. J Clin Microbiol. 2004 Mar;42(3):1254-6.
14. Guerrant RL, Steiner TS. Principles and Syndromes of Enteric Infection. In: Mandell GL, Bennett
JE, Dolin R editors. Mandell: Principles and Practice of Infectious Diseases, 6th ed., Copyright ©
2005 Churchill Livingstone, Inc. ch 89.
15. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al.; Infectious
Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin
Infect Dis. 2001 Feb 1;32(3):331-51. Epub 2001 Jan 30. Accessed August 4, 2006. Available at
URL address: http://www.journals.uchicago.edu/CID/journal/issues/v32n3/001387/001387.html
16. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, Lee AG. Measurement of fecal
lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 1992 May;30(5):1238-42.
17. Hanauer SB, Sandborn W; Practice Parameters Committee of the American College of
Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2001
Mar;96(3):635-43.
18. Holten KB. Irritable bowel syndrome: minimize testing, let symptoms guide treatment. J Fam
Pract. 2003 Dec;52(12):942-50.
Page 7 of 9
Coverage Position Number: 0414